Chimerix is a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes and provide hope for patients with life threatening diseases.

Mike Sherman

Chief Executive Officer and President

Mike Andriole

Chief Business and Financial Officer

W. Garrett Nichols, MD, MS

Chief Medical Officer

Michael A. Alrutz, JD, PhD

Senior Vice President, General Counsel

Randall Lanier, PhD

Chief Science Officer

Roy W. Ware, PhD, MBA

Chief Manufacturing and Technology Officer

Heather Knight-Trent, PharmD

Vice President of Regulatory Affairs

Odin Naderer, PharmD

Vice President, Clinical Pharmacology and Translational Medicine